AI Integration and Portable Innovations to Propel Ultrasound Devices Market at 4.12% CAGR till 2035
According to a detailed study by Market Research Future (MRFR), the Global Ultrasound Devices Market was valued at USD 11.66 billion in 2025 and is projected to reach USD 18.18 billion by 2035, registering a CAGR of 4.12% during the forecast period. The market growth is driven by technological advancements, increasing prevalence of chronic diseases, and rising demand for portable healthcare solutions. Continuous integration of AI-based imaging tools, growing adoption of non-invasive diagnostics, and increasing investment in point-of-care technologies further strengthen market expansion. Key players operating in the market include Esaote, Butterfly Network, Hologic, Samsung Medison, Royal Philips, Canon Medical Systems, GE Healthcare, and Siemens Healthineers.
Market Highlights
The Global Ultrasound Devices Market is witnessing steady transformation due to a surge in demand for efficient and patient-friendly diagnostic tools. The increasing preference for non-invasive imaging procedures and the availability of portable ultrasound systems have revolutionized access to diagnostics across hospitals and clinics. Moreover, AI integration in ultrasound equipment is enhancing image interpretation accuracy and workflow automation, allowing healthcare professionals to perform faster and more precise evaluations. Rising public awareness regarding the importance of early disease detection and preventive healthcare continues to shape market trends. The aging population, growing healthcare expenditure, and government initiatives supporting modern diagnostic infrastructure are further bolstering market expansion worldwide.
Segment Analysis
The Global Ultrasound Devices Market is segmented by Application (Diagnostic Imaging, Therapeutic Applications, Guided Interventions, Monitoring), Device Type (Portable Ultrasound Devices, Cart-based Ultrasound Devices, Stationary Ultrasound Devices), Technology (2D Ultrasound, 3D Ultrasound, 4D Ultrasound, Doppler Ultrasound), and End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Home Care Settings).
By Application, the market is led by the Diagnostic Imaging segment, which accounted for USD 3.2 billion in 2024, supported by widespread adoption in prenatal scans, organ assessments, and vascular imaging. Therapeutic Applications followed closely at USD 2.5 billion in 2024, driven by expanding use of ultrasound in physiotherapy, oncology, and targeted drug delivery. Guided interventions and monitoring applications are also gaining traction, aided by growing clinical acceptance and enhanced imaging precision.
By Device Type, the market comprises Portable, Cart-based, and Stationary Ultrasound Devices. Portable systems are witnessing rapid growth owing to their mobility, lower cost, and use in point-of-care diagnostics, especially in resource-limited regions. Cart-based devices remain the mainstay in hospitals due to their comprehensive imaging capabilities, while stationary systems are essential for specialized diagnostic centers requiring high-resolution imaging. These diverse configurations collectively address global healthcare needs, promoting accessibility and operational efficiency.
By Technology, the market includes 2D, 3D, 4D, and Doppler Ultrasound. The 2D modality continues to dominate due to its broad clinical utility and cost-effectiveness. The 3D and 4D segments are expanding as improved visualization supports better anatomical and functional assessments, particularly in obstetrics and cardiology. Doppler Ultrasound remains integral in vascular diagnostics, facilitating real-time blood-flow analysis. The increasing emphasis on early disease detection and image quality enhancement continues to drive innovation across these technologies.
By End User, the market covers Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, and Home Care Settings. Hospitals constitute the largest segment, as they serve as central facilities for comprehensive diagnostics and therapeutic procedures. Ambulatory surgical centers are gaining importance for outpatient imaging efficiency, while diagnostic centers expand with rising preventive-care awareness. The home-care segment, though emerging, is supported by the adoption of portable ultrasound devices, catering to aging populations and home-based monitoring solutions.
Regional Analysis
Regionally, the Ultrasound Devices Market exhibits balanced global distribution. North America dominated with a valuation of USD 3.01 billion in 2024 and is expected to reach USD 5.55 billion by 2035, supported by advanced healthcare infrastructure and strong adoption of medical technologies. Europe followed, valued at USD 2.2 billion in 2024 and projected to reach USD 4.21 billion by 2035, driven by rising investments in digital health and imaging modernization. The Asia-Pacific region was valued at USD 1.82 billion in 2024, reflecting strong growth in emerging markets such as China and India, supported by healthcare expansion and increasing affordability of diagnostic services. South America and the Middle East & Africa accounted for USD 0.73 billion and USD 0.26 billion in 2024 respectively, presenting high potential for future adoption as healthcare accessibility improves and awareness of ultrasound technology spreads.
Key Findings of the Study
• The Global Ultrasound Devices Market was valued at USD 11.66 billion in 2025 and is projected to reach USD 18.18 billion by 2035, growing at a CAGR of 4.12%.• Diagnostic Imaging remains the leading application segment due to extensive clinical use across specialties.• Portable ultrasound devices are expanding rapidly, addressing the need for point-of-care diagnostics.• 2D Ultrasound continues to dominate the technology segment, with 3D and 4D technologies showing strong growth potential.• Hospitals represent the largest end-user base, with home-care applications emerging steadily.• North America leads globally, followed by Europe and Asia-Pacific, while developing regions show increasing opportunities for market penetration.• Key players include Esaote, Butterfly Network, Hologic, Samsung Medison, Royal Philips, Canon Medical Systems, GE Healthcare, and Siemens Healthineers.